Omega

VC firm · Boston, MA

Verified active in the last 12 monthsSEC-registered adviser

Venture firm based in Boston, MA. Most recent fund on file: Omega Fund VIII, L.P. ($580M offering), filed Apr 2025. Partners sit on the boards of 7 startups that raised recently.

“We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas.” (from the firm’s website)

Stages: Seed to Growth
Typical check (est.): $5.8M–$17.4M
Latest fund: $580M · Apr 2025
Last verified activity: Jan 2026

Focus

Biotech & PharmaHealthcareAI & MLCybersecurity

Recent portfolio activity

Alveus Therapeutics
Board seat · PA
Jan 2026
Third Arc Bio
Board seat · PA
Aug 2024
Scorpion Therapeutics
Board seat · MA
Jul 2024
Spiro Medical
Board seat · FL
Oct 2023
Beta Bionics
Board seat · CA
Sep 2023
Ikena Oncology
Board seat · MA
Aug 2023

Funds and vehicles on SEC file

Omega Fund VIII, L.P.
Fund · $580M offering
Apr 2025

Sources

SEC Form D: Omega Fund VIII, L.P.Apr 22, 2025
SEC adviser record: Omega FUND Management, LLCMar 26, 2026
Firm websiteOct 12, 2026

Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.